Uncategorised - European Medical Journal

Telemedicine Reduces MASLD Risk in Adults with Diabetes - EMJ

Telemedicine Reduces MASLD Risk in Adults with Diabetes

Telemedicine nutrition care reduces MASLD and liver disease risk in adults with type 2 diabetes and obesity, showing promise for lifestyle-first interventions.

Novel MRI Boosts Detection of Stroke-Causing Plaques – EMJ

Novel MRI Boosts Detection of Stroke-Causing Plaques

New vessel wall MRI detects more supracardiac atherosclerosis plaques than CTA, improving stroke evaluation and identifying embolic sources.

Biomarker Discovery Reframes Schizophrenia Treatment

A single administration of SEAD1 into the prefrontal cortex restored disrupted E/I balance and improved synaptic function.

AI Uses Eye-Tracking Technology to Diagnose Autism

AI can distinguish children with autism spectrum disorder using eye-tracking technology with an accuracy of 85%, a 2026 systematic review has found.

More Than One Million People to be Offered Semaglutide on NHS

Semaglutide is set to be offered to more than one million people with cardiovascular disease on the NHS in coming months.

Eli Lilly office building

Lilly’s weight loss pill wins FDA approval

Eli Lilly won FDA approval on 1 April 2026 for a once-daily oral GLP-1, orforglipron.

Urinary Metabolites Identify Bladder Cancer and Predict Recurrence

Urinary metabolites may help detect bladder cancer and predict recurrence, offering a potential non-invasive tool to improve patient monitoring and outcomes.

New Trial Shows TENS Improves Pain in Fibromyalgia

Cluster trial shows TENS improves fibromyalgia pain with meaningful reductions sustained over six months and high patient satisfaction rates.

Hospital leadership team reviewing service pressures and crisis response planning in a clinical setting

Hospital Crisis Decision-Making Carries Hidden Risks

A qualitative study suggests hospital crisis decision-making can sideline routine care, while strengthening preparedness for later emergencies.

RAS inhibitors: risks after eGFR decline - EMJ

Stopping RAS Inhibitors After eGFR Fall May Increase Risk

Stopping RAS inhibitors after an eGFR decline may increase risk of kidney failure and death, according to a large cohort study.